{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:51:29Z","timestamp":1787507489860,"version":"build-2736575974"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We previously reported pain as a predominant finding in adult patients with X-linked hypophosphatemia (XLH). This study explored health-related quality of life using the 36-Item Short Form Survey Instrument (SF-36v1) and pain experiences of adults with XLH through qualitative analysis of interviews with 15 patients (11 females, 4 males). Age-adjusted differences using SF-36 were lower than the general population in all domains of health-related quality of life, with significant differences notably related to physical function and pain. Ten themes emerged from semi-structured interviews: (1) chronic and variable pain: patients reported persistent pain of varying intensity and location; (2) impact on mobility and daily life: pain severely restricted daily activities, affecting lifestyle, employment, and independence; (3) pain management: patients used medications, physical therapy, lifestyle changes, alternative therapies, and assistive devices; (4) healthcare and accessibility challenges: access to appropriate care and treatments was limited by insurance issues and healthcare providers\u2019 lack of XLH knowledge; (5) emotional and psychological impact: chronic pain and limitations led to social isolation, depression, and emotional burden; (6) desire for improved information and support: patients sought better information, treatment, and community support; (7) challenges with physical inactivity: staying active was essential but difficult, as inactivity worsened pain; (8) navigating healthcare services: accessing therapy and insurance was often challenging; (9) long-term outlook and concerns: patients worried about disease progression and future health; and (10) advocacy and awareness: increased public and medical awareness was needed to improve care. Although pain is not a universal experience within this population, it is a significant issue for many individuals with XLH. These data illustrate the profound impact of XLH on multiple life aspects underscoring the need for effective pain management strategies, better healthcare accessibility, supportive tools, and a more knowledgeable medical community to improve quality of life. Insights from this study will guide the development of a digital pain self-management intervention tailored to XLH patients to address these needs.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziaf012","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T15:20:23Z","timestamp":1737559223000},"source":"Crossref","is-referenced-by-count":2,"title":["Qualitative analysis of pain impact in adult patients with X-linked hypophosphatemia"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2202-1772","authenticated-orcid":false,"given":"Nicole","family":"Nishime","sequence":"first","affiliation":[{"name":"Frank H. Netter MD School of Medicine, Department of Medical Sciences, Quinnipiac University , North Haven, CT 06473 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-3765","authenticated-orcid":false,"given":"Christopher","family":"Theriault","sequence":"additional","affiliation":[{"name":"Connecticut Children\u2019s Research Institute , Department of Research Operations and Development, Hartford, CT 06106 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4158-7640","authenticated-orcid":false,"given":"Richard","family":"Feinn","sequence":"additional","affiliation":[{"name":"Frank H. Netter MD School of Medicine, Department of Medical Sciences, Quinnipiac University , North Haven, CT 06473 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1760-9678","authenticated-orcid":false,"given":"Carolyn M","family":"Macica","sequence":"additional","affiliation":[{"name":"Frank H. Netter MD School of Medicine, Department of Medical Sciences, Quinnipiac University , North Haven, CT 06473 ,","place":["United States"]},{"name":"Connecticut Children\u2019s Research Institute , Department of Research Operations and Development, Hartford, CT 06106 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025031810224083300_ref1","volume-title":"Dietary Phosphorus","author":"Macica","year":"2017","edition":"1st"},{"issue":"1","key":"2025031810224083300_ref2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00223-020-00729-9","article-title":"Role of phosphate in biomineralization","volume":"108","author":"Bhadada","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2025031810224083300_ref3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025031810224083300_ref4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2025031810224083300_ref5","doi-asserted-by":"publisher","first-page":"e1798","DOI":"10.1210\/clinem\/dgaa064","article-title":"Osteoarthritis, osteophytes, and enthesophytes affect biomechanical function in adults with X-linked hypophosphatemia","volume":"105","author":"Steele","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025031810224083300_ref6","doi-asserted-by":"crossref","first-page":"bvab070","DOI":"10.1210\/jendso\/bvab070","article-title":"Patient-reported complications, symptoms, and experiences of living with X-linked hypophosphatemia across the life-course","volume":"5","author":"Cheung","year":"2021","journal-title":"J Endocr Soc"},{"issue":"7","key":"2025031810224083300_ref7","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s11136-020-02465-x","article-title":"Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study","volume":"29","author":"Lo","year":"2020","journal-title":"Qual Life Res"},{"issue":"12","key":"2025031810224083300_ref8","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1210\/endo.139.12.6522","article-title":"Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice","volume":"139","author":"Karaplis","journal-title":"Endocrinology"},{"issue":"12","key":"2025031810224083300_ref9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMcpc059025","article-title":"Calcification of entheses associated with X-linked hypophosphatemic osteomalacia","volume":"353","author":"Polisson","journal-title":"N Engl J Med"},{"key":"2025031810224083300_ref10","volume-title":"The Burden of Musculoskeletal Diseases in the United States","author":"BMUS"},{"issue":"1","key":"2025031810224083300_ref11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2025031810224083300_ref12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.17294\/2330-0698.1727","article-title":"Giving credence to the experience of X-linked hypophosphatemia in adulthood: an interprofessional mixed-methods study","volume":"7","author":"Hughes","year":"2020","journal-title":"J Patient Cent Res Rev"},{"issue":"5","key":"2025031810224083300_ref13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s002239900715","article-title":"An atypical degenerative osteoarthropathy in Hyp mice is characterized by a loss in the mineralized zone of articular cartilage","volume":"65","author":"Liang","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2025031810224083300_ref14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00005792-198911000-00002","article-title":"X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults","volume":"68","author":"Reid","journal-title":"Medicine (Baltimore)"},{"key":"2025031810224083300_ref15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3389\/fcell.2020.00854","article-title":"Development of enthesopathies and joint structural damage in a murine model of X-linked hypophosphatemia","volume":"8","author":"Faraji-Bell\u00e9e","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2025031810224083300_ref16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1148\/radiology.171.2.2539609","article-title":"X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features","volume":"171","author":"Hardy","year":"1989","journal-title":"Radiology"},{"issue":"7","key":"2025031810224083300_ref17","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc"},{"issue":"12","key":"2025031810224083300_ref18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/2040622318804753","article-title":"Vibrational spectroscopic analysis of hydroxyapatite in HYP mice and individuals with X-linked hypophosphatemia","volume":"9","author":"Amenta","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"issue":"2","key":"2025031810224083300_ref19","first-page":"91","article-title":"Prevalence of dental abscess in a population of children with vitamin D-resistant rickets","volume":"13","author":"McWhorter","year":"1991","journal-title":"Pediatr Dent"},{"issue":"3","key":"2025031810224083300_ref20","doi-asserted-by":"crossref","first-page":"e001714","DOI":"10.1136\/rmdopen-2021-001714","article-title":"Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension","volume":"7","author":"Briot","year":"2021","journal-title":"RMD Open"},{"issue":"2-3","key":"2025031810224083300_ref21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.healthpol.2012.02.018","article-title":"How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient-physician interaction","volume":"105","author":"Budych","year":"2012","journal-title":"Health Policy"},{"issue":"12","key":"2025031810224083300_ref22","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jbmr.3843","article-title":"Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial","volume":"34","author":"Insogna","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025031810224083300_ref23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"19","key":"2025031810224083300_ref24","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11192628","article-title":"Pain care management in rare diseases","volume":"11","author":"Rodr\u00edguez-Merch\u00e1n","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"2025031810224083300_ref25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neubiorev.2021.02.009","article-title":"Pain phenotypes in rare musculoskeletal and neuromuscular diseases","volume":"124","author":"Tucker-Bartley","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"14","key":"2025031810224083300_ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148874","article-title":"Screening of patient impairments in an outpatient clinic for suspected rare diseases-a cross-sectional study","volume":"19","author":"Gutenbrunner","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"10189","key":"2025031810224083300_ref27","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"2025031810224083300_ref28","first-page":"2","volume-title":"SF-36 Health Survey: Manual and Interpretation Guide","author":"Ware","year":"1993"},{"key":"2025031810224083300_ref29","doi-asserted-by":"publisher","first-page":"20406223241247643","DOI":"10.1177\/20406223241247643","article-title":"Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis","volume":"18","author":"Boot","year":"2024","journal-title":"Ther Adv Chronic Dis"},{"key":"2025031810224083300_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2021.100883","article-title":"Innovation in the treatment of persistent pain in adults with neurofibromatosis type 1 (NF1): implementation of the iCanCope mobile application","volume":"25","author":"Buono","year":"2021","journal-title":"Contemp Clin Trials Commun"},{"issue":"12","key":"2025031810224083300_ref31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123213","article-title":"Maintaining engagement in adults with neurofibromatosis type 1 to use the iCanCope mobile application (iCanCope-NF)","volume":"15","author":"Buono","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2025031810224083300_ref32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/rheumatology\/keaa178","article-title":"The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial","volume":"60","author":"Lalloo","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2025031810224083300_ref33","first-page":"164","article-title":"A cognitive-behavioral digital health intervention for sickle cell disease pain in adolescents: a randomized, controlled, multicenter trial","volume":"165","author":"Palermo","year":"2024","journal-title":"Pain"},{"issue":"11","key":"2025031810224083300_ref34","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jpain.2021.04.006","article-title":"Sensory innervation of human bone: an immunohistochemical study to further understand bone pain","volume":"22","author":"Steverink","year":"2021","journal-title":"J Pain"},{"issue":"8","key":"2025031810224083300_ref35","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025031810224083300_ref36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/art.42299","article-title":"Concepts of entheseal pain","volume":"75","author":"De Lorenzis","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"646","key":"2025031810224083300_ref37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3399\/bjgp16X684901","article-title":"Understanding and managing dental and orofacial pain in general practice","volume":"66","author":"Renton","year":"2016","journal-title":"Br J Gen Pract"},{"issue":"8","key":"2025031810224083300_ref38","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac094","article-title":"An evidence-based physical therapy prescription for adults with X-linked hypophosphatemia","volume":"6","author":"Kanamalla","year":"2022","journal-title":"J Endocr Soc"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziaf012\/61587964\/ziaf012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/4\/ziaf012\/61587964\/ziaf012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/4\/ziaf012\/61587964\/ziaf012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:23:25Z","timestamp":1742279005000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziaf012\/7976667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf012","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,1,23]]},"article-number":"ziaf012"}}